Prabhudas Lilladher has come out with its fourth quarter (January-March’ 19) earnings estimates for the Pharma sector. The brokerage house expects Lupin to report net profit at Rs. 253.2 crore down 62.8% year-on-year (up 32.9% quarter-on-quarter). Net Sales are expected to increase by 2.1% Y-o-Y (down 7.2% Q-o-Q) to Rs. 4,061 crore.